The scramble to ramp up CGT production

There’s a lot of sorting out going on in the world of cellular and genetic therapies (CGTs) when it comes to “manufacturing” and “dispensing.” Manufacturing is in quote marks because, unlike nearly all biopharma products, CGTs usually start with a […]

Read More